OptimizeRx Corp — Director's Dealing 2018

Feb 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2018-02-01

Reporting Person: BAKER DOUGLAS P (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Restricted Stock Grant	$	A	50000	Acquired		Common Stock (50000)	Direct

Footnotes

F1: Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock.

F2: The reporting person received a restricted stock grant that may vest on either February 1, 2019 or February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals.

F3: Not applicable.